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DIAGNOSIS AND TREATMENT OF BORDERLINE LESIONS
ORAL PRESENTATIONS
A01 Desmoid Tumours. A Clinical Review of 30 Patients 
with more than 20 Years Follow-up
B.P.M. Dalén1, P. Bergh2, K. Berlin3, B. Gunterberg2
1Sahlgrenska University Hospital, Goteborg, Sweden, 2Sahlgren
University Hospital, Goteborg, Sweden, 3University of Goteborg,
Goteborg, Sweden
Objective:  To  assess  the  long-term  outcome  in  patients  with
desmoid tumours.
Methods: Thirty consecutive patients (20F, 10M) with a minimum
follow-up of 20 years (mean 28 years) were reviewed. The tumours
were located in the abdominal wall (7), upper extremity (6), lower
extremity (6), back (5), thoracic wall (4), head-neck region (1).
One patient had multifocal tumours. Twenty-nine patients  had
surgical treatment. Three received radiotherapy later in the course
of the disease. One had anti-estrogenic treatment in addition. The
surgical  margins  were  wide/radical  (10),  marginal  (13)  or
intralesional (6). One patient had radiotherapy alone. 
Results: At follow-up fifteen patients were continuously disease-
free after the first surgical treatment, nine patients had no evidence
of disease after surgery for recurrent tumours. Five patients were
alive with stable tumours. One tumour disappeared gradually after
radiotherapy only (39  Gy).  Two  patients  died  of  non-tumour-
related  causes  20  and  23  years  after  diagnosis.  The  overall
recurrence rate was 40%. Only 1 patient with wide/radical margin
had a recurrence. The mean time to first recurrence was 1.5 years.
Two patients were amputated, 4 patients had moderate – severe
post-treatment symptoms. 
Conclusion:  Desmoid tumours have an unpredictable development.
Long-term  survival  is  the  rule  regardless  of  recurrences. Some
disabling symptoms may be more related to over-treatment than
the tumour itself. New strategies are needed and are under way.
A02 Diagnostic Impact of Histologic Parameters in
Differentiating Enchondroma from Grade I Central
Chondrosarcoma
D. Eefting1, M.J.A. Geirnaerdt2, S. Le Cessie3, A.H.M. 
Taminiau4, P.C.W. Hogendoorn1
Departments of 1Pathology,  2Radiology,  3Medical Statistics and 
4Orthopedic Surgery, Leiden University Medical Center, Leiden,
The Netherlands
Introduction  and  objective:  Because  of  the  difference  in  clinical
management of enchondromas and central grade I chondrosar-
comas it is important to make a correct preoperative diagnosis. In
this  study  we  investigated  the  diagnostic  value  of  histologic
parameters in differentiating these tumours.
Materials and Methods: Cytologic and tissue-architectural features
of 57 patients (20 enchondromas and 37 central grade I chondro-
sarcomas) were assessed. The observer was aware of the tumour
localisation, age and clinical symptoms (swelling, pain or fracture).
A final diagnosis, using at least  10  years of follow-up after the
biopsy  in  case  of  diagnosis  of  enchondroma was  assessed  in  a
multidisciplinary setting with full clinicoradiological and pathology
data available. Tumours of the digits and toes were excluded. The
chi-square  test,  classification  trees  and  logistic  regression  were
used to assess the discriminating power of individual parameters
and to find an optimal set of differentiating parameters. 
Results: Entrapment of host lamellar bone, high cellularity, marked
nuclear pleomorphism and irregular cell distribution showed the
greatest discriminating value (p<0.001). The combination of high
cellularity, presence of host bone entrapment, open chromatin,
mucoid matrix quality >= 20% and age above 45 years allowed a
perfect prediction of diagnosis. A classification tree illustrated that
if mucoid matrix  degeneration is  more then 20%  or host bone
entrapment  is  present  (or  both),  the  tumour  is  with  close  to
certainty malignant. 
Conclusion:  Combination of 5 parameters (high cellularity, presence
of host bone entrapment, open chromatin, mucoid matrix quality
>= 20% and an age above 45 years) allowed optimal differentiation.
With a simple classification tree, based on 2 parameters (mucoid
matrix  degeneration more  then  20%  or  host  bone  entrapment
present or both), 54 of the 57 (94.7%) cases were assessed correct
(sensitivity 95% and specificity 95%). This approach, combined
with tailored radiology, will lead to optimal classification.
A03 Bcl-2 Immunohistochemistry as a Tool to Distinguish 
Osteochondroma and Grade I Peripheral Chondrosarcoma
J.V.M.G. Bovee, P. Kok, L.J.C.M. Van den Broek, P.C.W. 
Hogendoorn
Leiden University Medical Center, Leiden, The Netherlands
Objective  of  study:  Peripheral  chondrosarcoma arises  within  the
cartilaginous cap of an osteochondroma (osteocartilaginous exos-
toses). Osteochondromas occur solitary, or within the context of
hereditary  multiple  exostoses  (HME).  To  distinguish  between
benign and malignant can be difficult, both clinicoradiologically as
well as histologically. Recently we documented an upregulation of
PTHrP and Bcl-2, two proteins presumed to act downstream of
EXT (the genes involved in HME), characterising the progression
of osteochondroma towards peripheral chondrosarcoma. Our goal
was to evaluate whether the immunohistochemical detection of
Bcl-2  and/or  PTHrP  can  be  used  in  the  differential  diagnosis
between osteochondroma and grade I peripheral chondrosarcoma. 
Methods:  Using  the  national pathology database (PALGA),  we
retrieved  tissue  blocks  of  29  laboratories  in  The  Netherlands,
including 73  osteochondroma specimens  of 57  patients  and 43
grade  I  chondrosarcoma  specimens  with  documentation  of  a
(previous)  osteochondroma  of  40  patients.  Two  bone  tumour
pathologists reviewed diagnoses. PTHrP and Bcl-2 immunohisto-
chemistry was performed and scored semi-quantitatively by two
independent observers.
Results:  Bcl-2  expression was  absent  in osteochondromas (1/56
positive), while an upregulation was observed in a subset of chon-
drosarcomas (18/37 positive) (p=0.000 Fisher’s Exact Test). Bcl-
2 immunohistochemistry proved to be a strong diagnostic tool. In
case of any staining, both specificity and positive predictive value
were 59%. In case of moderate to strong or more diffuse staining,
a high specificity of 98% was found with a positive predictive value
of  95%.  Sensitivity  was  however relatively  low  (89%  and 49%
respectively). For PTHrP, variably intense staining was found in aS8 EMSOS abstracts
varying percentage of cells in both osteochondromas and chondro-
sarcomas, which made it a less suitable diagnostic marker. 
Conclusion: Bcl-2 Immunohistochemistry is a valuable immunohis-
tochemical test to distinguish osteochondroma and grade I periph-
eral  chondrosarcoma,  in  which  moderate  to  strong  or  diffuse
cytoplasmic staining is highly suggestive (95%) of malignancy. 
A04 The Treatment of Benign and Low-grade Malignant 
Intramedullary Chondroid Tumours with Curettage and 
Cryosurgery
H.W.B. Schreuder
University Medical Centre St. Radboud, Nijmegen, The Netherlands
Introduction:  Much controversy exists about the methods of staging
and treatment of enchondroma and low-grade chondrosarcoma,
because accurate distinction is hampered by their radiographically
and histologically similarity. The continuous spectrum of biolog-
ical behaviour of these entities is unpredictable and a benign lesion
as enchondroma can even differentiate in secondary chondrosar-
coma.  Because  of  low  recurrence  risk  limited  surgery  with  or
without adjuvant therapy is advocated. 
Method  and  patients:  Since  1991  we  treated  97  intramedullary
chondroid lesions in 94 patients with intralesional resection, local
adjuvant cryosurgery and bone grafting. All  cryosurgical proce-
dures  were  per-operatively  monitored using  thermosensors  and
real-time computerised graphical visualisation. Sixty-five patients
with 68 lesions had a follow-up of 2 years or more and are therefore
included  in  this  study.  All  patients  had  a  standard  follow-up
consisting of local radiographs and bone scan. MRI, CT and chest
X-ray were done on indication. 
Results:  One  lesion  (an aggressive  enchondroma located  in  the
hand)  recurred.  No  metastases  were  observed.  Complications
included one deep wound infection and 7 fractures; none of these
patients  underwent preventative osteosynthesis.  All  bone grafts
incorporated, resulting in full-weight-bearing capacity and good or
excellent functional results. 
Conclusion: For enchondroma (stage 2 and 3) and chondrosarcoma
grade 1 (stage IA), this  study  showed that  the  combination of
curettage and cryosurgery as adjuvant therapy can be considered to
be equal as marginal resection in terms of local tumour control. In
contrast  to  marginal  resection  the  treatment described  will  not
leave segmental bone defects, which are difficult to reconstruct.
Therefore all  patients  had good to  excellent  functional results.
Fracture is of concern, but along the learning curve and since the
use  of  preventative  osteosynthesis  this  complication  was  not
encountered anymore. 
A05 The Atypical Lipoma
S.M.M. Sommerville, J.T. Patton, J.C. Luscombe, R.J. Grimer
Royal Orthopaedic Hospital, Birmingham, United Kingdom
Aim: Significant controversy exists with regard to the nomencla-
ture,  treatment  and  outcome  of  a  group  of  well-differentiated
lipomatous tumours sometimes labelled as atypical lipomas. The
purpose of this paper is to attempt to clarify these controversies by
reporting our experiences with this lesion. 
Methods: Seventy-five patients with the diagnosis atypical lipoma
and  a  minimum  two-year  follow-up  were  identified  from  the
oncology  service  database  at  our  institution.  Records  were
reviewed to record the oncological outcome with particular note of
any local recurrence, metastasis, or dedifferentiation. 
Results:  Treatment  of  atypical  lipomas  at  this  institution  is  by
marginal resection alone. Sixty-five patients were treated here with
their primary lesion. Follow-up was a minimum of two years with
a mean of 49 months (range 24 to 114 months). Five patients had
a local recurrence (7.7%). Four recurred once and one recurred
twice. No patient had a metastasis or died as a result of the tumour.
No lesion dedifferentiated. Nine of the ten patients seen here with
a presumed recurrence actually had a recurrent atypical lipoma.
Recurrences were treated by further marginal resections and one
went on to have a further recurrence. None of these patients had a
metastasis and no lesion dedifferentiated. The final patient with a
suspected recurrence most likely had a radiation-induced sarcoma
nine years following radiotherapy after the marginal excision of a
recurrent atypical lipoma. 
Conclusion:  We believe the term atypical lipoma is appropriate for
these tumours, as they appear not to have any metastatic potential,
merely a propensity to recur locally. The chance of dedifferentia-
tion is very small and the role of radiotherapy in the causation of
dedifferentiation is uncertain. We suggest that a simple marginal
resection  (shelling-out)  is  adequate treatment  for these  lesions.
Radiotherapy should not be used. 
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A06 IHH/PTHRP and BMP Receptors Expression 
Discriminate among Cartilaginous Lesions
J. Warzecha, E. Lucarelli, L. Zanella, M. Alberghini, G.A. Gobbi, 
V. Maini, P. Bacchini, P. Picci, F. Bertoni, L. Sangiorgi
Istituti Ortopedici Rizzoli, Bologna, Italy
Objective: Indian Hedgehog (and its downstream target) and Bone
Morphogenic  Proteins  have  shown  to  play  a  relevant  and
independent  role  in  chondrocyte  proliferation  and  regulations
during embryonic development. Aim of this study is to evaluate if
the  expression  of  these  molecules  can  be  used  for  diagnostic
classification of cartilaginous lesions. 
Methods: 92 cartilaginous lesions were analysed by immunohisto-
chemistry with the antibodies for Indian Hedgehog (Ihh), Parath-
yroid  Hormone  related  peptide  (PTHrp),  Bone  Morphogenic
Protein Receptors type 1 A (BMPR-IA), type 1B (BMPR-IB) and
type 2 (BMPR-II) receptors. Staining was evaluated by 4 investi-
gators independently. 
Results:  We  observed  a  distinct  pattern  of  expression  of  these
proteins in specific subset of cartilaginous lesions. Ihh and BMPR-
II expression were found in 4,9% and 5,1% of osteochondromas.
In contrast, the same antigens were expressed in 54,1% and 48,3%
of peripheral chondrosarcomas. In central chondroid lesions, two
different proteins, PTHrp and BMPR-IB showed a similar pattern
of expression distinguishing between enchondromas (11,1% and
25%) and grade I chondrosarcomas (67,7% and 79,5%). 
Conclusion:   Immunohistochemical  detection  of  these  proteins
could identify different subset of cartilaginous lesions and could be
useful for diagnostic purposes. 
A07 Impact of Limited Resection on Outcome in Patients 
with (OFD-like) Adamantinoma
H.E. Henkus1, B.H.W.G.M Smit2, H.M. Hazelbag3, P.C.W. 
Hogendoorn1, A.H.M. Taminiau1
1Leiden University Medical Center, Leiden, The Netherlands, 
2Department of Orthopaedics, Vancouver, Canada, 3Department of 
Pathology, Leiden University Medical Centre, Leiden, The Netherlands
Background:  (osteofibrous-dysplasia-like)  adamantinoma  is  an
intracortical lesion with various degrees of intramedullary involve-
ment.  Intercalary grafting  with  osteosynthesis  or  amputation is
associated with significant morbidity. Using MRI a more sparingEMSOS abstracts S9
procedure might be considered that preserves the continuity of the
bone. Reconstruction with inlay graft and minimal osteosynthesis
allows future MRI. 
Objective:  Evaluate  middle/long-term  functional  and  oncologic
Results of en-bloc resection with reconstruction with auto-or allo
inlay grafts with minimal osteosynthesis in patients with (OFD-
like) adamantinoma of the long bones. 
Methods: Clinical and radiographic data of 18  patients between
1986 and 2001 were reviewed. The diagnosis (OFD-like) adaman-
tinoma was based on radiographic and histopathological findings.
Sex: male: 6; female: 12 
Symptoms none: 3 pain/swelling: 15 
Location: diaphysis tibia: 16 metaphysis tibia: 2 
Diagnostic  procedure: jamshidi  biopsy:  12  incisional  biopsy:  3
curretage: 2 
Histological  classification:  OFD-like  adamantinoma:  13  classic
adamantinoma: 4 
Treatment: inlay graft: 13 Intercalary graft preserving a periosteal
sleeve: 5 
Average age at the time of surgery: 23 years (8–38 years). Surgery:
MRI-guided en-bloc resection. Reconstruction: tibial/fibular auto/
allograft. Osteosynthesis: no to 4 screws. Follow-up: repetitive X-
rays  and MRI.  Incorporation was  defined  as  the  absence of  a
radiolucent line at the host-donor junction with smooth external
continuity of cortical bone. Functional outcome: MSTS-score. 
Results: The average length of defect: 11.3 cm (6–21 cm). Compli-
cations: Intra-operative: fracture host cortex: 2 (both needed oste-
osynthesis,  one  after  casting  because  of  hypertrophic
pseudoarthrosis).  Postoperative:  infections/wound  problems:  0,
neurological: 1  (dropfoot), reflex  dystrophy:  1.  Late  complica-
tions: fracture through graft: 2 (both because of trauma) Average
immobilisation-time: 3 months. Average graft consolidation-time:
8 months (2–24). Mean disease-free interval: 69 months (1–149).
Local recurrence: 1 (with sarcomatous dedifferentiation. Died of
metastatic  disease).  Average  MSTS-score:  24/30  [80%  (range
0–100)]. 
Conclusion:  En-bloc resection with reconstruction using an inlay
graft with minimal osteosynthesis is an oncologically sound proce-
dure with good functional result. The risk of a fracture should be
minimised  by  using  cast  or  brace  protection  sometimes  for  a
prolonged period. 
A08 Enchondroma – Indications for Surgical Treatment and 
Follow-up
P.E.M. Mueller1, H.R. Dürr1, B. Wegener1, A. Von Liebe1,
C. Pellengahr2, V. Jansson1
1University of Rostock, Germany, Rostock, Germany, 2University
Munich Grosshadern, Munich, Germany
Enchondromas  are  benign  cartilaginous  tumours.  Rarely  these
transform into chondrosarcomas. Curettage and bone grafting is
usually  performed  assuming  a  low  rate  of  complications.  We
analysed  data  from  73  patients  with  enchondromas treated  by
curettage between 1980 and 1997 retrospectively with respect to
symptoms, therapy, complications and recurrences. For compar-
ison we included data from all cases of chondrosarcomas in the
same period. 68 patients had solitary and five multiple enchon-
dromas. All patients were treated by curettage of the tumour, in
most cases followed by cancellous bone grafting. 23% of patients
suffered a complication. There were two recurrences but no malig-
nant transformation in  the  follow-up period. In  the same  time
period 29 patients with chondrosarcomas were treated, including
two  secondary  chondrosarcomas.  One  had  a  recurrence  of  a
benign enchondroma of the fifth metacarpal (no histological signs
of malignancy) and developed a pulmonary metastasis of a chond-
rosarcoma 52 months later. The other is a patient with Ollier’s
disease with several enchondromas at different sites  who had a
secondary chondrosarcoma of the right radius. 
Conclusion:  Malignant transformation of a solitary enchondroma to
a  chondrosarcoma  is  rare.  But  the  complication  rate  of
enchondroma curettage is considerable. Thus regular follow-up of
asymptomatic enchondromas with radiographs may be the better
option. 
A09 Differentiation of Enchondroma and Low-grade
Chondrosarcoma – Clinicopathological and Radiological 
Findings in 34 Cases
H. Welkerling1, S. Kratz2, G. Delling3, V. Ewerbeck4
1Universitaetsklinik fuer Orthopaedie, Graz, Austria, 2Inst. Of 
Diagnostic Radiology, Erlangen-Nuernberg, Germany, 3Hamburg 
University Institute of Pathology, Hamburg, Germany, 4Depart. Of 
Orthopaedic Surgery, Heidelberg, Germany
18  low-grade  chondrosarcomas  (CS  1)  and  16  enchondromas
(EC) were analysed in a retrospective study. The purpose of the
study was to compare histological, clinical and radiological finding
of EC and CS 1 in order to select criteria of malignancy. 
Methods: 18 patients with CS 1 and 16 with EC were treated at the
Department  of  Orthopaedic  Surgery  of  Heidelberg  University.
The study included analysis of histological material, evaluation of
x-rays and clinical data. EC were strictly differentiated from CS 1
by growth pattern.
Results: The mean age of patients with EC and CS 1 was similar
(44 versus 46 years). The mean follow-up time was 40 months in
CS 1 and 29 months in EC. 87.5% of CS 1 patients reported pain,
whereas only 43.8%  of EC did. This difference was significant
(p=0.009). Cellularity, the quantity of double nuclei and mitosis
did not show any significant differences between EC and CS 1.
Both entities are characterised by small, isomorphic nuclei. Signif-
icant difference could be observed concerning cortical destruction
between EC and CS 1 (19% versus 94%). None of the EC, but
44% of the CS 1 lesions had an extra-osseous component. Local
recurrence could not be observed in EC, but in 11% of CS 1 after
intralesional or marginal procedure. 
Conclusion:  In contrast to patients with EC, those with CS 1 usually
had history of pain, and the radiological findings of CS 1 were
much more aggressive. EC and CS 1 are distinguishable by growth
pattern, but not by cytological features. Cortical destruction, the
presence of an extra-osseous component and pain are suspicious of
malignancy in differentiation of EC and CS 1, especially if the
histological findings are unclear. 
A10 Surgical Treatment of Border Line and Low Grade 
Malignant Intramedullary Chondroid Tumours
P.D. Daolio, G. Oldani, G. Perrucchini, F. Lazzaro, R. Zorzi,
P. Zacconi, A. Parafioriti, S. Mapelli
Istituto Ortopedico ‘Gaetano Pini’, Milano, Italy
Some chondroid lesions of bone represent a considerable problem
for  the pathologist  because  the distinction between benign  and
low-grade malignant tumours should be hard to share. We revised
the patient files in all cases with cartilaginous lesions classified as
borderline or low-grade chondrosarcoma (stage I A). From 1957
to 1988  we treated 84  patients  with chondroid tumours. 24  of
them were classified as low grade or borderline lesions. Most of
them were treated by bone resection. Since 1988, according to
other Authors studies, low-grade malignant and borderline lesions
of long bones, have been treated by deep curettage, adjuvant and
acrylic  cement.  From  December  1988  to  February  2001,  114
patients were operated because of a cartilaginous lesion. 39 wereS10 EMSOS abstracts
classified as low grade or borderline lesions (27 intramedullary and
12 peripheral lesions). We studied the central lesion: in 18 patients
we  performed  deep  curettage,  adjuvant  and  acrylic  cement,  9
patients were treated by bone resection (pelvic and spine sites).
Although the follow up of 7 of them, is less then 5 years, as all the
patients are continuously disease free, conservative surgery seems
to be a satisfactory method for local control of these tumours.
A11 How Spreads GCT?
M.S.J. Mikel, E.N. 1 Noain, C. Villas
University Clinic of Navarra, Pamplona, Spain
Objective: Bone GCT is supposed to be a benign lesion, but it can
produce pulmonary metastases. Some times local control can be
achieved by intralesional surgical procedures, such as curettage,
but en-block excision is preferable for avoiding recurrences. The
authors present a series of GCT treated in the same institution
focusing in the ways of spreading of those which recurred. 
Methods: Since 1967, 57 GCT were treated at our institution and
16 were referred after being treated elsewhere. Expert pathologists
made histological diagnosis and grading according to Jaffe scale.
The most frequent locations were distal femur and proximal tibia.
Simple x-rays of the location of the tumour and chest were used for
the follow-up in all cases. MRI was used also since 1990. 
Results: 17 cases recurred in the primitive bone location, two in an
adjacent  bone,  one  in  a  distant  bone,  1  in  the  soft  tissues
surrounding the bone, and one in distant soft tissues. Two cases
progressed  to  fibrosarcoma  after  irradiation  elsewhere.  No
pulmonary  metastases  were  seen  in  this  series,  except  in  the
aforementioned cases of fibrosarcoma. No cases of lymph node
dissemination  were  seen.  No  relationship  between  histological
grade (Jaffe) and recurrence was seen. 
Discussion: GCT can not only locally recur, but also can spread to
the  surrounding bones and soft tissues.  A case of intra-arterial
spread to distant soft tissues was also seen. The mechanisms of
spreading of this tumour remain controversial, since even after en-
block excision recurrence is  possible,  while other cases may be
cured after curettage. The use of adjuvants such as cement, phenol
or cryosurgery can diminish the risk of recurrence but no data were
found to predict the outcome. 
A12 Intra-articular Osteoid Osteomas
P. Cool, V. Pullicino, D. Williams, A. Darby
RJAH Orthopaedic Hospital, Oswestry, United Kingdom
It has been reported that osteoid osteomas regress spontaneously
and that  treatment  can be  conservative with  anti-inflammatory
medication. Others advocate active treatment with thermocoagu-
lation  of  these  lesions.  Intra-articular  Osteoid  Osteomas  do
normally not have the intense reactive bone formation as is often
seen in Osteoid Osteomas in other locations. Consequently, juxta-
articular Osteoid Osteomas are more difficult to diagnose and the
diagnosis is often made late. We investigated the natural history of
intra-articular Osteoid Osteomas that presented to our centre. We
also reviewed 10 patients with intra-articular Osteoid Osteomas
that had been reported by our centre 10 years previously. The diag-
nosis was histologically proven in all cases. All patients reviewed
had early radiographic arthritic changes to the involved joint and
one  patient  required  joint  replacement  surgery  for  end  stage
osteoarthritis. It is postulated that Osteoid Osteomas originate an
intense  inflammatory  reaction  whatever  there  location.  If  the
location is juxta-articular, it results in intense synovitis rather then
the more classical periostitis with reactive new bone formation. We
recommend  that  once  a  diagnosis  of  intra-articular  osteoid
osteoma is made, the patient should be treated actively with ther-
mocoagulation. Delay in treatment will result in early arthritis with
destruction of the joint. 
A13 Treatment and Outcome of Low-grade 
Chondrosarcoma
D.A. Campanacci, G. Beltrami, P. De Biase, A. Astone, M. Pietri, 
R. Capanna
Centro Traumatologico Ortopedico, Firenze, Italy
Low-grade  chondrosarcoma  (CHS)  (grade  1)  has  a  scarce
tendency to local recurrence and metastatic dissemination. Some
cartilaginous lesions present clinical, radiographical and histolog-
ical features, which are, defined borderline between a benign chon-
droma and a malignant CHS. The appropriate approach towards
these  lesions  has not been clearly defined yet and surgeons are
debating between clinical observation of the patient and surgical
treatment with curettage or resection. The authors analyse their
experience  on  low-grade  CHS  with  the  aim  to  define  surgical
guidelines on the basis of clinical, radiographical and histological
considerations. A series of 32 grade 1 CHS was reviewed occurring
in 31 patients (one patient had two localisations). Seven patients
had a peripheral CHS and in 25 cases a central CHS was observed.
The surgical treatment was a resection in 26 cases and intralesional
curettage in 6 cases. At an average follow-up of 44 months, no local
recurrence and/or  metastatic  dissemination  was  observed in 30
cases, while in two patients, both treated with surgical resection, a
local recurrence occurred. Both patients underwent an amputation
and  a  progression  of  malignancy  to  a  high-grade  CHS  was
observed  at  histology.  In  both  cases,  metastatic  dissemination
occurred. From the analysis of the data it appears that a lesion
showing  the  radiographical  features  of  a  cartilaginous  tumour,
when  it  is  painless,  with  no  endosteal  cortical  scallopping,
extending for less than 5 cm in the medullary canal, should be
followed in time with clinical and radiographical observation. In
the  other  cases,  a  biopsy  should  be  performed  of  a  specimen
including the cortex and the transition area between the cortex and
the tumour. When the histological diagnosis indicates a borderline
lesion  an accurate  curettage  with  the  use  of  local  adjuvants is
recommended. In case  of  grade 1 CHS, a resection  with wide
margins should be performed. 
A14 Medial Acetabular Cysts – A Cause for Concern
J. Rees, S.O. Hill, D.H. Williams, V. Pullicino, P. Cool
The Orthopaedic Hospital, Shropshire, United Kingdom
Introduction:  Acetabular cysts  are a common finding in patients
with osteoarthritis of the hip. These mainly occur in the weight
bearing superior part of the acetabulum. At our institute we have
had 7 cases of medial acetabular wall cysts, which presented with
hip pain mimicking that of osteoarthritis. All these cysts turned out
to be malignant in origin. The aim of this study was to identify the
distribution, position and multiplicity of acetabular cysts in oste-
oarthritis of the hips and highlight the importance of the finding of
medial acetabular cysts. 
Methods: The radiographs of the 7 cases of medial acetabular cysts
were analysed and compared with the pre-operative radiographs of
100 consecutive patients who had a total hip replacement for oste-
oarthritis. The presence of acetabular cysts was recorded, as well
as their number and location within the acetabulum, using a modi-
fication of DeLee and Charnley zones. All patients had a minimum
follow-up of  1  year. We  excluded  patients  with  any history  of
malignant disease or inflammatory arthropathy. EMSOS abstracts S11
Results: Overall half the cases of osteoarthritis were associated with
acetabular cysts.  All  had other  radiographic features  consistent
with osteoarthritis. The majorities of the cysts were multiple in
number and were found in the weight-bearing supra-medial and
supra-lateral  region  of  the  acetabulum.  None  were  found  to
involve the medial wall of the acetabulum. Of the malignant medial
wall cysts, none had features suggestive of osteoarthritis. 
Conclusion:  Multiple and solitary acetabular cysts are common in
patients  with  osteoarthrosis.  They  occur  predominately  in  the
weight bearing zones of the acetabulum and are always associated
with other osteoarthritic changes. Isolated medial acetabular cysts
do not occur in osteoarthrosis and require further investigation to
confirm their nature. 
A15 Is Treatment with Curettage and Phenol Allowed for 
Low Grade Central Chondrosarcoma?
S.H.M. Verdegaal, P.C.W. Hogendoorn, A.H.M. Taminiau
Leiden University Medical Center, Leiden, The Netherlands
Introduction:  Low-grade central chondrosarcomas of the extremi-
ties were treated by local resections with wide margins. Although it
is adequate surgery, morbidity is to concern. Since 1994 we started
to  treat  low-grade  chondrosarcoma  by  intralesional  surgery
(curettage) in combination with adjuvant therapy (phenol). 
Purpose: Is treatment with curettage and phenol safe and allowed
for low-grade chondrosarcoma? 
Methods: From 1988 on 23 patients were treated for low-grade chon-
drosarcoma. (10 resection, 13 curettage/phenol). PA-diagnosis: 7
borderline, 16 grade I chondrosarcoma. Excluded are low-grade
chondrosarcoma of juxtacortical origin, or secondary to osteochon-
droma. All cases were controlled by X-rays and repeated dynamic
MRI. 
Results: Resection group (10), female (7), male (3), average follow
up 93,6 months (42–164), Proximal femur (3), distal femur (2),
proximal humerus (1), distal  humerus (1), proximal fibula (1),
radius (1) and digits III (1). For reconstruction allograft (3), allo-
graft and prosthesis (4) or prosthesis (1) were used. Mean surgery
time 3 h 30 min, average admission 13.6 days (4–28). 
Complications:   2  non-union  allograft  (28.5%),  1  subcutaneous
infection. Intralesional group (13), female (9), male (4), average
follow up 62 months (45–89). Distal femur (6), proximal tibia (1),
proximal humerus (4), metacarpal bone (1). Mean surgery time 1
h 25 min, average admission 4.6 days (3–10). 12 Patients were
treated  by  adjuvant phenolization  after  curettage.  1  Male  was
treated with curettage alone, because cortex was destructed. This
patient had the only recurrence, after 2 years. In no other case,
controlled by X-ray or MRI, recurrence was found. 
Conclusion:  Although we realise that follow up time is still short and
number of treated patients is relatively small, only one recurrence
is seen (curettage without phenol). No other recurrence or metas-
tasis is seen and all patients are still alive. In our opinions there is
a place for intralesional treatment of central borderline and grade
I chondrosarcoma, followed by adjuvant therapy. Longer follow up
is  necessary, because local recurrence might  be expected in the
intralesional surgery group.
A16 Clear Cell Chondrosarcoma (CCC): The Rizzoli 
Institute Experience
M. Donati, A. Colozza, L. Perna, P. Picci, F. Bertoni, M. Mercuri
Istituti Ortopedici Rizzoli, Bologna, Italy
From 1969, 24 cases of clear cell chondrosarcoma (CCC) were
registered in the Rizzoli Bone Tumour archive. The histological
review excluded 5 more cases: 4 due to more aggressive attitude
(2 dedifferentiation in Osteosarcoma and 2 high grade Chondro-
sarcoma) and 1  resulted  as a  Chondroblastoma. In the left  19
cases, age ranged from 24  to 61  years (mean 37), tumour was
located  in  the  proximal  femur  in  9  cases  (47%),  proximal
humerus  2,  acetabulum  2,  and  distal  femur,  proximal  tibia,
scapula,  1st  lumbar  vertebra,  5th  rib  and  talus  1  each.  Eight
cases were previously treated in other institutions  (7 curettages
and 1 osteosynthesis), while our treatment was resection. Among
the 11 cases primarily treated by us, 3 were curetted. Pain was
present at diagnosis from 3 to 48 months (mean 24). In 5 cases
the patient arrived to the hospital because a pathologic fracture.
Fourteen patients  have been  followed more  than 5 years: time
ranging from 74 to 241 (mean 140) months. The classical roent-
genographic feature of a CCC is  a clear margin, lytic  lesion in
the  proximal  femoral  neck. It  is  frequently misinterpreted  as  a
chondroblastoma, central chondrosarcoma or giant cell tumour;
however, in other locations the tumour may mimic several more
lesions as osteoblastoma, low grade osteosarcoma and fibrosar-
coma.  Only  two  patients  experienced  recurrence  and  are  now
alive without evidence of disease after  62  and 28  months after
the  excision  of  the  recurrent  tumour.  None  of  the  3  curetted
cases showed recurrent tumour after a mean follow-up time  of
16  years  (10  to  18  years).  No  metastatic  lesions  have  been
observed. 
Conclusion:  In the majority of the cases CCC behaves as a very low-
grade malignant tumour, however it is important to avoid under-
estimating a more aggressive lesion resembling a CCC; resection
seems to be the better surgical approach. 
A17 Strategy of Treatment in Desmoid Tumours 
(Aggressive Fibromatosis in Children and Adults):
to Avoid Absolutely Radiotherapy
N. Delépine, S. Alkallaf, B. Markowsha, H. Cornille,
I.M. Bigirimana, G. Delépine
Avicenne Hospital, Bobigny, France
In Desmoid tumour, frequent relapses are able to threaten life or
conservation of limb. To point out the best indications of treat-
ment, we reviewed our cases. From 1981 to 2000, we treated 50
patients (age 28 (1–70), locations were inferior limb (19), superior
limb (17), axial (9), head and neck (5). 17 patients were seen at
first  hand,  33  with  relapses.  Treatment  was  adapted  to  each
patient. En bloc extratumoural resection was performed each time,
when surgery didn’t expose to heavy functional consequences (22).
14 patients received chemotherapy. 10 received Interferon a , and
9 tamoxifen. 
Results: Mean FU is 6 years ½>. 34 patients are in CR, 9 in SD, 6
PD,  1  died  with  thoracic  complications.  Following  repeated
surgery, functional consequences are numerous: 8 nerve palsies, 8
articular  stiffness.  Major  functional  consequences  came  from
surgery with radiotherapy. In one, radiotherapy of a cervical lesion
led to impossibility of surgery and to death. The analysis of our
series leads to schematise the indications: 
– If  the  tumour  doesn’t  threaten  life  or  limb,  only  surgery  is
needed as large as possible, avoiding functional consequences. 
– When tumour relapses appear, Tamoxifen must be discussed. 
– When the tumour invades noble structures, preoperative chem-
otherapy is useful, in order to soften the tumour and to help
surgery. 
Conclusion:  in this  unforeseeable illness,  backgrounds of indica-
tions are respective risks of spontaneous evolution and of treat-
ment.  Besides  surgery,  needed  in  fast  all  cases,  but  often
insufficient,  it  must  be  considered  the  value  of  interferon,
tamoxifen  and/or  chemotherapy.  The  most  important  concept
in the  necessity  to  adapt  a  well-balanced  treatment  avoidingS12 EMSOS abstracts
consequences  and  particularly  radiotherapy.  This  last  attitude
leads to most heavy consequences and therapeutic deadlocks.
A18 The Solitary Bone Lesion. A Consecutive Series of 
Aggressive Solitary Bone Lesions in Patients Over the Age 
of Forty
J.T. Patton, J. Luscombe, S. Sommerville, R. Grimer
Royal Orthopaedic Hospital, Birmingham, United Kingdom
The purpose of this study is to investigate the causes and charac-
teristics of the aggressive solitary bone lesion in patients over the
age of forty. Over a four-year period, 318 patients over the age of
forty were referred to our institution with what we would define as
an aggressive solitary bone lesion. Further investigation and diag-
nostic biopsy as appropriate were performed in all patients. The
lesions were then defined according to their radiological appear-
ance, pathology and site.  The nature of these  lesions  was then
subdivided into several broad groups. A diagnosis of primary bone
sarcoma  was  found  in  30%  of  these  lesions.  Plasmacytoma,
lymphoma and metastases accounted for 13% each. Benign bone
tumours, infection and non-oncological diagnoses accounted for
9%, 6% and 16% of lesions respectively. Aggressive solitary bone
lesions are often due to primary bone sarcomas. Metastases from a
previously unrecognised primary malignancy account for less than
one sixth of lesions. This study emphasises the need for appro-
priate  investigation  and  biopsy  of  the  aggressive  solitary  bone
lesion. 
A19 Multiple Osteochondromas – Complications and 
Malignant Transformation
Z. Matejovsky, Z. jr. Matejovsky, C. Povysil
Hospital Bulovka, Prague 8, Czech Republic
Multiple osteochondromas (MO), or multiple exostoses, diaphy-
seal  aclasia,  is  a  hereditary  disorder  with  autosomal  dominant
heredity. We  have reviewed 117  cases in our registration as  to
complications and malignant transformation. 
Methods & Results: In the years 1966–1998 (33 years) we have
registered 117 patients with MO, 64 men and 53 women. The
youngest patient was a girl one-year of age, the daughter of one of
our MO patients who died of malignant transformation. The eldest
patient was 83 year, who was admitted for another diagnosis. He
knew about his disorder since childhood, but he never did seek
medical advice. The average age of patients at the time of diagnosis
or when they were admitted for treatment was 20 year in men and
18 in women. The extent of skeletal involvement varied from a few
small  exostoses  to  severe  deformities.  Shortening  of  ulna  and
bowing of radius was frequent in severe cases and was treated by
surgery.  We  registered  two  cases  of  femoral  artery  aneurysm
caused by a needle sharp exostosis. In three of our patients chond-
rosarcomatous transformation occurred, two of them died, one is
alive  ten  years  after  amputation.  In  addition,  one  large  and
increasing  exostosis  was  removed  from  the  pelvis,  where  only
clinical signs of tumour progression were present and histology was
unclear. 
Conclusion: From our series  of patients  it  seems  that malignant
transformation in MO is less frequent than usually given in the
literature, amounting to 3, 4%. Nevertheless the patients should be
under  permanent  control  and  should  be  informed  about  the
possibility of progression into a malignant tumour.
A20 Periosteal Osteosarcoma – Should They all have 
Chemotherapy? The Case for Another Emsos Study
R.J. Grimer, M.P. Revell, N. Deshmukh
Royal Orthopaedic Hospital, Birmingham, United Kingdom
Introduction:  Periosteal osteosarcomas are rare cartilage-rich bone
tumours characterised by a juxtacortical eccentric position. While
there is general agreement that wide surgical excision is required,
there is a paucity of evidence regarding adjuvant therapy. Previous
reports have not indicated any consistent approach to this to allow
appraisal. We compare our experience with previous studies  to
evaluate both surgical and oncological methods of treating this
tumour. 
Methods: We retrospectively reviewed seventeen cases treated at
our centre over sixteen years. All patients underwent surgery to
remove the tumour. Limb reconstruction was usually necessary
either at the time of primary excision or subsequently. Our policy
was to use chemotherapy when the tumour showed any features of
high grade. 
Results: 10/17 patients received an endoprosthesis primarily, 4/17
had excision only and 3/17 excision and bone graft. 14/17 received
chemotherapy.  There  was  one  local  recurrence in  the  excision
group  treated  by  re-excision  and  endoprosthesis.  To  date,  no
deaths have resulted from recurrence or metastasis of the tumour
although there have been two deaths from other causes. 
Discussion:  Our  survival  figures  compare  favourably with  those
reported previously. We suggest that this is probably the result of
the evolution of surgical techniques and the contribution of adju-
vant therapy. Further research is required to establish who benefits
most from chemotherapy, but at present we would recommend it
be considered in all cases of periosteal osteosarcoma showing any
features of high grade. 
A21 Bone Giant Cell Tumour and Lung Metastases: A 
Surgical Approach
M. Rocca, A. Briccoli, P. Picci, P Ruggieri, M Mercuri
Istituti Ortopedici Rizzoli, Bologna, Italy
Benign giant cell tumour of bone (GCT) rarely gives lung metas-
tases. Data acquired from literature showed that lung metastases
could follow different development pathways: spontaneous remis-
sion, remain unchanged for a long period, or increase. The Rizzoli
Institute archives registered to December 2001 1090 patients with
GCT (6% of all bone tumours). Sixteen patients (1.5%) under-
went surgery, by the same team, for lung metastases. Nine were
males, and seven females, the age ranging from 16 to 62. The site
of primary bone tumour was the upper limb in 5 cases, lower limb
in 10 cases, spine in 1 case. In 10 cases a local recurrence was
evident. Lung metastases were unilateral in 8 cases. The average
disease free interval from the onset of the primary tumour was 32
months in 14 patients; in 2 patients lung metastases were evident
at presentation. All patients were operated with a contemporary
mono or bilateral thoracotomy and a wedge resection was made.
The average number of resected metastases was 6 (from 1 to 20).
All  patients were followed by repeated thoracic CT scan. Nine
patients were freed by metastases and are continuous disease free
(average  follow-up  92.1  months).  Five  patients  are  alive  with
disease (average follow-up 55.8 months). Two patients died. The
presence of a local recurrence is a risk factor for lung metastases,
which can appear also after a long period of time following surgery
of the primary tumour. 
Conclusion:  considering the low surgical risk and the opportunity for
some patients to freed of the disease, resection of lung metastases
from bone GCT is mandatory when their volume increases in time. 